Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07636148
What this trial is testing

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

Who this might be right for
Liver Cancer (Primary and Metastatic)Lung Cancer (Diagnosis)Bone Cancer Metastatic+10 more
Mark C Burgmans, MD PhD 2,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05661955
What this trial is testing

Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaMelanoma+1 more
BeiGene 113
Large-scale testing (Phase 3)Study completedNCT02030717
What this trial is testing

Randomized Study of Spinal Anesthesia Compared With Traditional Epidural Anesthesia Concerning Peroperative and Postoperative Pain After Open Nephrectomy in Patients With Renal Cell Carcinoma

Who this might be right for
Pre- and Postoperative AnalgesiaSpinal AnesthesiaRenal Cell Carcinoma
Umeå University 120
Large-scale testing (Phase 3)Active Not RecruitingNCT01575548
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
National Cancer Institute (NCI) 129
Testing effectiveness (Phase 2)UnknownNCT02398552
What this trial is testing

A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.

Who this might be right for
Metastatic Renal Cell Carcinoma
Peking University Cancer Hospital & Institute 80
Large-scale testing (Phase 3)Active Not RecruitingNCT03815643
What this trial is testing

Avelumab Program Rollover Study

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 205
Testing effectiveness (Phase 2)Study completedNCT01731158
What this trial is testing

Sequential Therapy in Metastatic Renal Cell Carinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Central European Society for Anticancer Drug Research 22
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)WithdrawnNCT03323710
What this trial is testing

Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Military Institute od Medicine National Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT00324740
What this trial is testing

Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 14
Early research (Phase 1)Active Not RecruitingNCT05122546
What this trial is testing

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Papillary Renal Cell CarcinomaAdvanced Renal Cell Carcinoma+9 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT00096525
What this trial is testing

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07043608
What this trial is testing

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Clear Cell Renal CarcinomaClear Cell Renal Cell Carcinoma Metastatic+7 more
Kelly Fitzgerald, MD 20
Large-scale testing (Phase 3)Study completedNCT00053820
What this trial is testing

Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical Research Council 670
Testing effectiveness (Phase 2)Study completedNCT00467025
What this trial is testing

AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib

Who this might be right for
Advanced Renal Cell Carcinoma
Amgen 152
Early research (Phase 1)Study completedNCT04440943
What this trial is testing

The PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerBreast CancerGastric Cancer+11 more
Celldex Therapeutics 27
Not applicableLooking for participantsNCT07321197
What this trial is testing

Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC)

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)
Tianjin Medical University Second Hospital 220
Testing effectiveness (Phase 2)Study completedNCT00480389
What this trial is testing

Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal

Who this might be right for
Renal Cell CarcinomaMetastatic Disease
University Health Network, Toronto 19
Not applicableUnknownNCT04245410
What this trial is testing

Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma

Who this might be right for
Surgical ProcedureDisease Free SurvivalOverall Survival
Universidad de Extremadura 100
Testing effectiveness (Phase 2)Looking for participantsNCT05663710
What this trial is testing

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

Who this might be right for
Advanced CancerClear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 100
Next Page